Jianming Wang

Dr. Jianming Wang


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2021 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
PDF file
HLHongsong Li
Hongsong Li
RLRong Li
Rong Li
LWLijun Wang
Lijun Wang
DLDingying Liao
Dingying Liao
WZWenyi Zhang
Wenyi Zhang
JWJianming Wang
Jianming Wang

18 March 2020 in International Journal of Ophthalmology
Verified
Journal Article
Open access
XYXi-Ting Yang
Xi-Ting Yang
LZLin Zhao
Lin Zhao
LWLi-Jun Wang
Li-Jun Wang
YZYi Zhang
Yi Zhang
DLDing-Ying Liao
Ding-Ying Liao
JWJianming Wang
Jianming Wang
AIM: To evaluate the intraocular pressure (IOP)-lowering efficacy and safety of tafluprost 0.0015% eye drops [benzalkonium chloride (BAK) 0.1 mg/mL] compared with that of latanoprost 0.005% eye drops (BAK 0.2 mg/mL) for primary open angle glaucoma (POAG) and ocular hypertension (OHT). METHODS: All the randomized controlled trials (RCTs) about treating POAG and OHT comparing tafluprost and latanoprost were collected by searching PubMed, Embase, Cochrane Library, CNKI and VIP. The outcomes of interest to evaluate the clinical efficacy and adverse effects included IOP and patient-related drop discomfort. RESULTS: Five RCTs involving 888 glaucoma patients were included. The results showed that, 1) at the end of the study, no statistically significant differences were observed in IOP reduction [standard mean difference (SMD) =0.48, 95%CI 0.07 to 0.88, P=0.085] between tafluprost and latanoprost; 2) No statistically significant differences were observed in adverse events of foreign-body sensation [relative risk (RR) =0.62, 95%CI 0.26 to 1.46, P=0.269], eye irritation (RR=1.16, 95%CI 0.49 to 2.75, P=0.744), eye pain (RR=2.000, 95%CI 0.949 to 4.216, P=0.07), iris hyper-pigmentation (RR=0.741, 95%CI 0.235 to 2.334, P=0.61), dry eye (RR=1.154, 95%CI 0.409 to 3.256, P=0.79) and eye pruritus (RR=1.600, 95%CI 0.536 to 4.774, P=0.4) between tafluprost and latanoprost. However, tafluprost showed more reported incidence of conjunctival hyperaemia than latanoprost (RR=2.11, 95%CI 1.24 to 3.59, P=0.006). CONCLUSION: Tafluprost 0.0015% eye drops (BAK 0.1 mg/mL) and latanoprost 0.005% eye drops (BAK 0.2 mg/mL) are comparable in lowering IOP for open angle glaucoma (OAG) and OHT. It does not differ in the incidence of foreign-body sensation, eye irritation, eye pain, iris hyper-pigmentation, dry eye and eye pruritus, but tafluprost shows less ocular tolerability because of more incidence of conjunctival hyperaemia.

30 January 2023 in Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
HLHongsong Li
Hongsong Li
LWLijun Wang
Lijun Wang
MSMeilin Shao
Meilin Shao
MRMeimei Ren
Meimei Ren
WZWenyi Zhang
Wenyi Zhang
JWJianming Wang
Jianming Wang
Aim. Pirfenidone (PFD), an antifibrotic drug, has various beneficial functions such as antioxidant, antifibrotic, and anti‐inflammatory effects. This study aimed to explore the molecular mechanisms underlying how PFD modulates retinal pigment epithelial (RPE) cells involved in neovascularization and subretinal fibrosis. Methods. ARPE‐19 cell lines were treated with transforming growth factor‐beta 2 (TGF‐β2) alone or in combination with PFD. RPE cell viability, as a consequence of PFD use, was determined by the CCK‐8 assay. Cell migration was assessed by the wound closure assay and quantified by the Image J software. Protein expression of the following markers was measured by the western blot analysis: an epithelial cell marker and E‐cadherin; mesenchymal cell markers, fibronectin, matrix metalloprotein‐9 (MMP‐9), and alpha‐smooth muscle actin (α‐SMA); a fibrotic marker and connective tissue growth factor (CTGF); an angiogenesis marker and vascular endothelial growth factor (VEGF); NF‐κB/Snail. The mRNA levels of fibronectin and α‐SMA were determined by quantitative real‐time PCR. VEGF was quantitatively measured by the enzyme‐linked immunosorbent assay. Results. The cell viability assay revealed that PFD had no significant cytotoxic effect on RPE cells at concentrations of less than 1 mg/mL. The cell scratch assay showed that TGF‐β2 stimulation significantly improved the migration of RPE cells and that PFD attenuated this effect. PFD significantly inhibited the TGF‐β2‐induced protein expression of E‐cadherin and increased the TGF‐β2‐induced protein expression of fibronectin, MMP‐9, α‐SMA, CTGF, and VEGF in ARPE‐19 cells. The mRNA expression of fibronectin and α‐SMA was inhibited by PFD in TGF‐β2‐inducedARPE‐19 cells. Additionally, the increased intracellular and supernatant expression of VEGF protein was suppressed by PFD. Mechanistically, RPE cells treated with PFD + TGF‐β2 exhibited a decrease in phosphorylation of the NF‐κB P65 subunit and activation of Snail, compared with the RPE cells treated with TGF‐β2 alone. Conclusion. PFD ameliorated TGF‐β2‐induced neovascularization and fibrosis by suppressing the NF‐κB/Snail signaling pathway. Therefore, PFD may be a potential drug in the treatment of age‐related macular degeneration.

26 April 2018
Verified
Journal Article
Open access
YZYi Zhang
Yi Zhang
LZLin Zhao
Lin Zhao
LWLijun Wang
Lijun Wang
XYXiting Yang
Xiting Yang
AZAiyi Zhou
Aiyi Zhou
JWJianming Wang
Jianming Wang
Purpose: To investigate the role of placental growth factor (PGF) in the epithelial-mesenchymal transition (EMT) of ARPE-19 cells under hypoxia, and whether the NF-kappa B signaling pathway is involved in this process. Methods: ARPE-19 cells were treated in five groups: a control group, hypoxia group, PGF group, hypoxia+PGF group, and NF-kappa B-blocked group. A chemical hypoxia model was established in the ARPE-19 cells by adding CoCl2 to the culture medium. The morphological changes after treatment were observed. The proliferation rates were measured with 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. The migration abilities were measured with scratch assay. The EMT biomarkers were measured with quantitative real-time PCR (qRT-PCR), western blotting, and immunofluorescence. The relative protein expression of components of the NF-kappa B signaling pathway was measured with western blotting and immunofluorescence. Results: Cells treated with PGF under hypoxia exhibited morphological changes consistent with the transition from an epithelial to a mesenchymal phenotype. In the ARPE-19 cells, exogenous PGF under hypoxia increased the proliferation rate compared to the rate under hypoxia alone (p<0.05) and increased the migration rate (p<0.05). Treatment of hypoxiaexposed cells with PGF caused decreased expression of the epithelial biomarkers E-cadherin and ZO-1 (both p<0.05) and increased expression of the mesenchymal marker alpha-SMA (p<0.05) by enhancing the phosphorylation of NF-kappa B p65 of the total protein, promoting the translocation of p65 to the nucleus, and inducing the degradation of I kappa B-alpha (a negative regulator of the NF-kappa B pathway) in the ARPE-19 cells. Additionally, the effect of PGF-induced EMT in the ARPE-19 cells under hypoxia was counteracted with BAY 11-7082 (a selective NF-kappa B inhibitor). Conclusions: Exogenous PGF promotes EMT-like changes in ARPE-19 cells under hypoxia by activating the NF-kappa B signaling pathway. The study results suggest that PGF may play a role in scar formation in neovascular age-related macular degeneration (AMD) and that the inhibition of PGF may be a promising target for the prevention and treatment of AMD.

1 October 2021 in Experimental Cell Research
Verified
Journal Article
Closed access
LWLijun Wang
Lijun Wang
HLHongsong Li
Hongsong Li
WZWenyi Zhang
Wenyi Zhang
MRMeimei Ren
Meimei Ren
MSMeilin Shao
Meilin Shao
JWJianming Wang
Jianming Wang

19 August 2019 in Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
LWLijun Wang
Lijun Wang
LZLin Zhao
Lin Zhao
XYXiting Yang
Xiting Yang
YZYi Zhang
Yi Zhang
DLDingying Liao
Dingying Liao
JWJianming Wang
Jianming Wang
Purpose. To compare visual performance and visual quality outcomes after phacoemulsification with two different clear corneal incision (CCI) distances anterior to the limbus in senile cataract patients. Methods. Retrospective case series. Patients who had undergone phacoemulsification were divided into two groups according to the CCI distances anterior to the limbus. The CCI distances in group A range from 1 mm to 1.5 mm, while those in group B range from 0.5 mm to 1 mm. The visual acuity, refraction, surgically induced astigmatism (SIA), corneal aberrations, anterior segment parameters, and subjective vision quality were evaluated. Results. This study enrolled 54 eyes, with 27 eyes per group. Both groups had significant improvement in postoperative uncorrected visual acuity (UCVA) and corrected distance visual acuity (CDVA) (P<0.05). There were no statistically significant between-group differences in postoperative UDVA, CDVA, SIA, corneal aberrations, anterior segment parameters, or VF-QOL questionnaire performance (P>0.05). Conclusions. The phacoemulsification with CCI distances ranging from 0.5 mm to 1.5 mm is an effective and safe therapy to senile cataract. The CCI distance anterior to the limbus that ranges from 0.5 mm to 1.5 mm is recommended for routine phacoemulsification.